Transcripts

Iovance Biotherapeutics (IOVA) earnings call transcripts

Earnings call transcripts for Iovance Biotherapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as proof that demand, manufacturing scale and cost discipline are improving together, while deferring revised full-year guidance until Q3 visibility improves.

    Aug 06, 2026Confident0.82